Medical News

RSS

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

In the international CONVINCE trial, presented today (15 May 2024) at the European Stroke Organisation Conference (ESOC) 2024, anti-inflammatory treatment with long-term colchicine did not reduce rates of recurrent stroke and cardiovascular events in patients with non-cardioembolic stroke in the primary intention-to-treat analysis.

16 May 2024

Mechanistic insights into the role of huc-mscs in treating acute liver failure

Acute liver failure (ALF) is a life-threatening clinical problem with limited treatment options. Administration of human umbilical cord mesenchymal stem cells (hUC-MSCs) may be a promising approach for ALF.

16 May 2024

Unraveling the mystery of Alzheimer's resilience at molecular level

Everyone experiences aging in their own way, and factors such as genetics, lifestyle and environment play a role in this process.

16 May 2024

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

In this interview conducted at Pittcon 2024 in San Diego, we spoke to this year's Keynote Speaker Professor Omowunmi (Wunmi) Sadik about how sustainable nanomaterials are transforming human health.

From Pittcon 16 May 2024

Clinical trial suggests hypertension self-management strategies may be effective to control blood pressure

The study findings suggest that self-management strategies for hypertension may effectively reduce blood pressure levels over 24 months without increasing healthcare resource utilization or adverse events as compared to usual care.

16 May 2024

Does discrimination cause harm to the body?

Researchers investigate whether experiencing discrimination is associated with accelerated biological processes of aging.

16 May 2024

Cervical cancer rates drop significantly among vaccinated women

The efficiency of the HPV vaccination program in reducing the prevalence of cervical cancers.

16 May 2024

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Closed Loop Medicine Ltd, a leading TechBio company developing combination prescription drug plus software therapy products that deliver personalized dose optimization, and Pharmanovia, a global pharmaceutical company that commercializes novel medicines and revitalizes, extends and expands the lifecycle of established medicines, today announced the initiation of their OptiZest study, ID: NCT06372470, and first patient recruitment.

From Closed Loop Medicine 16 May 2024

Gut microbiota and obesity: New study shows promising results with probiotic and prebiotic intervention

The effect of a low-calorie, sufficient fiber regimen combined with probiotic supplements and physical activity on health, body composition, and physique.

16 May 2024

Rapid Novor teams up with PMCC to evaluate EasyM™ for multiple myeloma minimal residual disease monitoring

Rapid Novor Inc., a global leader in mass spectrometry (MS)-based antibody protein sequencing, today announced that the first patient has been enrolled in a new clinical study titled 'Clinical evaluation of EasyM™ for disease response analysis in newly diagnosed MM patients (NDMM)'.

From Rapid Novor Inc 16 May 2024

Medics at UCLA protest say police weapons drew blood and cracked bones

Inside the protesters’ encampment at UCLA, beneath the glow of hanging flashlights and a deafening backdrop of exploding flash-bangs, OB-GYN resident Elaine Chan suddenly felt like a battlefield medic.

16 May 2024

California’S $12 billion Medicaid makeover banks on nonprofits’ buy-in

For much of his young life, Jorge Sanchez regularly gasped for air, at times coughing so violently that he'd almost throw up. His mother whisked him to the emergency room late at night and slept with him to make sure he didn't stop breathing.

16 May 2024

DeNovix releases new budget-friendly 1 µL UV-Vis spectrophotometer

DeNovix introduces the DS-7 Spectrophotometer, a new 1 uL UV-Vis spectrophotometer in the DS-Series Quantification Range.

From DeNovix Inc. 16 May 2024

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

RedShiftBio, a leader in innovative biophysical characterization and bioprocess analytical solutions, proudly announces the launch of Aurora TX at The Protein & Antibody Engineering Summit (PEGS), kicking off on May 13, 2024, in Boston, MA. Aurora TX is the company's latest, most advanced instrument featuring ground-breaking MMS technology, and sets a new standard in biomolecular analysis by providing ultra-sensitive, ultra-precise measurements of biomolecule structure and stability, now enhanced with the addition of thermal ramping capability.

From RedShiftBio 16 May 2024

Medical News

CONVINCE trial reveals the effect of long-term colchicine on recurrent stroke and cardiovascular events

Mechanistic insights into the role of huc-mscs in treating acute liver failure

Unraveling the mystery of Alzheimer's resilience at molecular level

Sensing a Healthier Future with Sustainable Nanomaterials and Biosensors

Clinical trial suggests hypertension self-management strategies may be effective to control blood pressure

Does discrimination cause harm to the body?

Cervical cancer rates drop significantly among vaccinated women

Closed Loop Medicine and Pharmanovia commence OptiZest study for their first precision medicine combination therapeutic

Gut microbiota and obesity: New study shows promising results with probiotic and prebiotic intervention

Rapid Novor teams up with PMCC to evaluate EasyM™ for multiple myeloma minimal residual disease monitoring

Medics at UCLA protest say police weapons drew blood and cracked bones

California’S $12 billion Medicaid makeover banks on nonprofits’ buy-in

DeNovix releases new budget-friendly 1 µL UV-Vis spectrophotometer

RedShiftBio launches Aurora TX: Revolutionizing RNA and protein analysis with ultra-sensitive microfluidic modulation spectroscopy and thermal ramping capability

Nanoscribe partners with Advanced BioMatrix to offer 4 new bioresins for Quantum X bio

Study uncovers sex differences in brain responses to low sexual desire

Severe traffic injuries in Finland result in major financial burdens, with direct costs dominating within the first year

Does internet use boost psychological well-being?

New study uncovers 17 genes driving clonal hematopoiesis and links to aging and disease

Microplastics found in human blood: potential cardiovascular threat

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News